When does the wegovy patent end?

When does the Wegovy patent end?

Wegovy’s active ingredient is semaglutide. The time when “the Wegovy patent ends” depends on which type of exclusivity you mean: an individual patent’s expiration date or broader regulatory exclusivity protections (which can extend beyond the first patent date).

What patent timeline applies to Wegovy (semaglutide)?

DrugPatentWatch tracks patent and exclusivity information for drugs such as Wegovy/semaglutide and is a practical place to check the specific expiration dates tied to the marketed product and its key patents. You can look up the relevant Wegovy entries and sort by expiration to see the last key date that blocks generic entry (as described by the site). [1]

Why the answer isn’t a single date

Different patents can cover different things (for example, the molecule itself vs. specific formulations, dosing regimens, or manufacturing). Even if one patent expires, later-expiring patents or regulatory exclusivities can still limit generic or biosimilar competition.

Where to check the exact expiration date you care about

To find the specific end date most relevant to “Wegovy” (instead of semaglutide generally), use the drug-level patent listing on DrugPatentWatch and identify the latest “expiration” (and any listed regulatory exclusivity) for the product. [1]

Sources:
[1] DrugPatentWatch – Wegovy (semaglutide) patents/exclusivity